Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Thibault Geoui

Thibault Geoui

Website:

About the author: Thibault has been working for over 10 years in the life-sciences industry. He studied Sciences because he likes to understand how things work, he then moved into the biotech industry to see amazing discoveries translated into real-life applications. As an academic researcher in nanobiology, Thibault contributed to the first structural genomics program on the Epstein-Barr Virus (EBV), which resulted in 3 publications in international peer reviewed journals. He worked as a global product manager at QIAGEN where he launched over 30 laboratory products, improving the productivity of protein-scientists in Academia, and in the Pharma/Biotech industry. Thibault joined Elsevier in 2011; as director of solutions marketing he manages a portfolio of online products including Reaxys, the flagship chemistry solution. Thibault has a critical impact on the product roadmap, he believes in data and market research to drive product development and to uncover what will deliver real customer-value. He is currently working on a project that will re-defined how chemists use information solutions … stay tuned!

Posts by Thibault Geoui

A new relationship with Information

Posted on April 5th, 2016 in Chemistry

Today, new drugs emerge from a diverse landscape of players that includes Pharmaceutical and Biotech companies, as well as Academia – a veritable ecosystem of innovation. The role of Academia in this ecosystem is unique. (more…)

ACS San Diego Focuses on Computers + Chemistry

Posted on March 10th, 2016 in Chemistry

As I write this I am getting ready to travel to the 251st ACS National Meeting in San Diego, which starts this Sunday, March 13. I look forward to this year’s event which focuses on a theme that really resonates with me. Kenneth Merz, Jr., San Diego Thematic Program Chair for ACS notes that this year’s meeting: (more…)

Catalyzing Decisions in Pharma-Biotech Collaborations

Posted on March 4th, 2016 in Pharma R&D

Despite large strides in technological and scientific progress, the cost to develop and release a new drug has escalated dramatically (1). At the same time, the number of generic drugs has grown in the last decade (2). In the U.S., 70% of (more…)

Of People with Ideas: Strengthening an ecosystem of innovation

Posted on February 18th, 2016 in Pharma R&D

In the last three decades, the pharmaceutical industry has undergone a transformation unprecedented in the nearly 100-year history of prescription drugs. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6